Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4780301
Max Phase: Preclinical
Molecular Formula: C51H75N13O11
Molecular Weight: 1046.24
Molecule Type: Unknown
Associated Items:
ID: ALA4780301
Max Phase: Preclinical
Molecular Formula: C51H75N13O11
Molecular Weight: 1046.24
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCCN)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC1=O
Standard InChI: InChI=1S/C51H75N13O11/c1-30(2)25-35-45(70)57-31(3)43(68)62-38(27-33-17-9-6-10-18-33)49(74)64-24-14-21-40(64)50(75)63(4)39(20-11-12-22-52)48(73)61-36(26-32-15-7-5-8-16-32)46(71)59-34(19-13-23-55-51(53)54)44(69)56-29-41(65)58-37(28-42(66)67)47(72)60-35/h5-10,15-18,30-31,34-40H,11-14,19-29,52H2,1-4H3,(H,56,69)(H,57,70)(H,58,65)(H,59,71)(H,60,72)(H,61,73)(H,62,68)(H,66,67)(H4,53,54,55)/t31-,34-,35-,36-,37-,38-,39-,40-/m0/s1
Standard InChI Key: FLTIMXZSLYRKOV-MLBYUUQRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1046.24 | Molecular Weight (Monoisotopic): 1045.5709 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kemker I,Schröder DC,Feiner RC,Müller KM,Marion A,Sewald N. (2021) Tuning the Biological Activity of RGD Peptides with Halotryptophans†., 64 (1.0): [PMID:33356253] [10.1021/acs.jmedchem.0c01536] |
Source(1):